Swift Run Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-16,298
Closed -$3.75M 56
2016
Q3
$3.75M Buy
16,298
+5,085
+45% +$1.24M 2.2% 19
2016
Q2
$2.59M Sell
11,213
-5,775
-34% -$1.33M 1.65% 20
2016
Q1
$4.55M Buy
16,988
+5,940
+54% +$1.7M 2.82% 17
2015
Q4
$3.45M Sell
11,048
-17,230
-61% -$5.13M 2.02% 20
2015
Q3
$7.69M Buy
28,278
+110
+0.4% +$33.8K 4.01% 10
2015
Q2
$8.55M Sell
28,168
-230
-0.8% -$68.6K 3.61% 13
2015
Q1
$8.45M Buy
+28,398
New +$8.1M 3.68% 13

Other funds holding AGN

Swift Run Capital Management's AGN Position: Q4 2016 in Review

Swift Run Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 16,298 shares — an estimated $3.75M sold.

Swift Run Capital Management first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $8.55M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Swift Run Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Swift Run Capital Management sold 16,298 Allergan plc shares in Q4 2016, an estimated $3.75M.
  • Swift Run Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Swift Run Capital Management's Allergan plc position peaked at $8.55M in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Swift Run Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.